RESI Boston Investor Speakers

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

RESI Boston brings together active early-stage investors and life science innovators for two days of investor-led programming focused on capital, partnering, and market dynamics shaping healthcare innovation.

The agenda will feature leading biotech VCs, family offices, corporate scouts, health system investors, and impact-focused investors sharing how they evaluate opportunities, where they see momentum, and what founders need to understand as they prepare to raise capital and build strategic partnerships.

From Boston’s biotech ecosystem and early-stage therapeutic investing to pharma partnering, health systems, strategic capital, chronic disease, women’s health, family offices, and impact investing, the panel program offers practical insight across the full life science financing landscape.

These conversations are designed to help entrepreneurs better understand investor priorities, refine their fundraising strategy, and build relationships with the people actively shaping the future of healthcare innovation.

RESI Boston takes place in person September 22–23 at the Westin Copley Place, with virtual partnering September 25 and September 28–29. Whether attending in Boston or virtually, participants can connect with investors, gain perspective from the panel stage, and advance their next conversations through targeted partnering.

Featured RESI Boston Investor Speakers
John Abeles Northlea Partners	Marc Appel Pacific Bridge NY	Farnaz Bakhshi ACS BrightEdge
Caleb Bell Beyond Next Ventures	Alan Chiu Breakthrough T1D	Scott Davis Sontag Foundation
Ronald Dorenbos BioFrontline Ltd.	Shane Duffy Avanos Medical, Inc.	Tao Fang MRL Ventures Fund (MRLV)
David Fogel Mass Medical Angels	Navin Govind Evidence Ventures	Nimisha Gupta Jazz Pharmaceuticals, Inc
William Hsu, PhD NuFund Venture Group	Austin Hwang Analog Garage	Jonathan Ilicki Industrifonden
Renaud Jacquemart Omnium Global	Rohit Jain HBS Alumni Angels of Northern California	Satoshi Konagai Astellas Venture Management (AVM)
Jason Kraus Boston Harbor Angels	Kathy Ku Sazze Partners	Sally Wang Liang Xpanse Venture
Nate Macht ACS BrightEdge	Nune Martiros Paladin Capital Group	Andrew Merken Polsinelli PC
Nikhil Mutyal AstraZeneca	Rohit Nuwal TELUS Ventures	Maggie O'Toole LabCentral
Soyoung Park 1004 Venture Partners	Dushyant Pathak Autobahn Labs	Garrett Peterson Yahara Ventures
Andrew Rae Woodgreen Ventures	Parthiban Rajasekaran Sanofi	Armin Rump Otsuka Pharmaceutical Co., Ltd.
Mo Soleja Golden Seeds	Yvanka de Soysa Foreground Capital	Daniel Teper YADAY Health
Andrew Thomson Ipsen S.A.	John Tremblay Launchpad Venture Group	Le Zhan Yunion Healthcare Ventures